Boussard & Gavaudan Investment Management’s Health Assurance Acquisition Corp. Warrants HAACW Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio HAACW Stock Details HAACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$1K	–	163
2022 Q3	$1K	Hold	50,000	–	–	﹤0.01%	152
2022 Q2	$9K	Hold	50,000	–	–	﹤0.01%	124
2022 Q1	$27K	Hold	50,000	–	–	﹤0.01%	62
2021 Q4	$43K	Hold	50,000	–	–	﹤0.01%	131
2021 Q3	$52K	Hold	50,000	–	–	﹤0.01%	124
2021 Q2	$90K	Hold	50,000	–	–	0.01%	88
2021 Q1	$127K	Buy	+50,000	New	+$170K	0.01%	85

Boussard & Gavaudan Investment Management's HAACW Position: Q4 2022 in Review

Boussard & Gavaudan Investment Management sold out of Health Assurance Acquisition Corp. Warrants (HAACW) in Q4 2022, closing a stake of 50,000 shares — an estimated $1K sold.

Boussard & Gavaudan Investment Management first reported a position in HAACW in Q1 2021 and held it in 7 quarters. The position peaked at $127K in Q1 2021. 0 funds tracked by Wall St. Rank hold HAACW as of Q4 2022.

Boussard & Gavaudan Investment Management reported no remaining Health Assurance Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 50,000 Health Assurance Acquisition Corp. Warrants shares in Q4 2022, an estimated $1K.
Boussard & Gavaudan Investment Management first reported a position in Health Assurance Acquisition Corp. Warrants in Q1 2021 and held it in 7 quarters.
Boussard & Gavaudan Investment Management's Health Assurance Acquisition Corp. Warrants position peaked at $127K in Q1 2021.
0 funds tracked by Wall St. Rank held Health Assurance Acquisition Corp. Warrants as of Q4 2022.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.